12:00 AM
 | 
Dec 16, 2013
 |  BC Week In Review  |  Company News  |  Other News

Impax, Purdue Pharma neurology news

Purdue will grant Impax rights to sell undisclosed, defined quantities of a generic or authorized generic version of reformulated OxyContin oxycodone "starting...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >